MX2008013777A - Usos medicos adicionales de la proteina antisecretora. - Google Patents

Usos medicos adicionales de la proteina antisecretora.

Info

Publication number
MX2008013777A
MX2008013777A MX2008013777A MX2008013777A MX2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A
Authority
MX
Mexico
Prior art keywords
caveolae
dysfunction
lipid rafts
antisecretory protein
receptors
Prior art date
Application number
MX2008013777A
Other languages
English (en)
Spanish (es)
Inventor
Hans-Arne Hansson
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of MX2008013777A publication Critical patent/MX2008013777A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2008013777A 2006-04-27 2007-04-27 Usos medicos adicionales de la proteina antisecretora. MX2008013777A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600933 2006-04-27
US92082607P 2007-03-30 2007-03-30
PCT/SE2007/000415 WO2007126365A2 (en) 2006-04-27 2007-04-27 Further medical uses of antisecretory protein

Publications (1)

Publication Number Publication Date
MX2008013777A true MX2008013777A (es) 2009-02-03

Family

ID=38655930

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008013777A MX2008013777A (es) 2006-04-27 2007-04-27 Usos medicos adicionales de la proteina antisecretora.

Country Status (10)

Country Link
US (1) US8487074B2 (https=)
EP (1) EP2037950B1 (https=)
JP (2) JP5508846B2 (https=)
KR (1) KR20090037992A (https=)
AU (1) AU2007244005B2 (https=)
CA (1) CA2650132C (https=)
IL (1) IL194775A (https=)
MX (1) MX2008013777A (https=)
PL (1) PL2037950T3 (https=)
WO (1) WO2007126365A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008013769A (es) * 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Uso de factores antisecretores para el tratamiento de hipertension intraocular.
MX2008013777A (es) 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Usos medicos adicionales de la proteina antisecretora.
KR101757523B1 (ko) 2006-04-27 2017-07-12 란트만넨 아스-팍토르 아베 구획 증후군의 치료에 사용하기 위한 항분비 단백질
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
WO2010093324A1 (en) * 2009-02-11 2010-08-19 Lantmännen As-Faktor Ab Use of antisecretory factors (af) for optimizing cellular uptake
WO2010065342A1 (en) 2008-11-25 2010-06-10 Temple University Angiocidin inhibition of tumor cell growth
US11253552B2 (en) 2015-07-10 2022-02-22 Lantmännen As-Faktor Ab Process for producing egg yolk with high content of AF-16
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
JP7217760B2 (ja) * 2018-06-28 2023-02-03 ラントメネン・メディカル・アーベー 急性呼吸不全の治療および/または予防の使用のための抗分泌因子
WO2022159845A1 (en) * 2021-01-22 2022-07-28 University Of Virginia Patent Foudation Altering protein function by pharmacological targeting of membrane domains

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585401A (en) 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
JP2000506375A (ja) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
MX2008013777A (es) 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Usos medicos adicionales de la proteina antisecretora.
KR101757523B1 (ko) * 2006-04-27 2017-07-12 란트만넨 아스-팍토르 아베 구획 증후군의 치료에 사용하기 위한 항분비 단백질
EP2682819A2 (en) * 2012-07-04 2014-01-08 Xeikon IP B.V. A method for forming a multi-colour image

Also Published As

Publication number Publication date
IL194775A0 (en) 2011-08-01
CA2650132A1 (en) 2007-11-08
AU2007244005B2 (en) 2012-08-02
HK1128237A1 (en) 2009-10-23
EP2037950A2 (en) 2009-03-25
KR20090037992A (ko) 2009-04-17
JP2009535330A (ja) 2009-10-01
WO2007126365A8 (en) 2009-03-05
EP2037950B1 (en) 2014-04-23
AU2007244005A1 (en) 2007-11-08
JP2014111623A (ja) 2014-06-19
JP5508846B2 (ja) 2014-06-04
IL194775A (en) 2015-09-24
WO2007126365A3 (en) 2008-03-13
US20090149382A1 (en) 2009-06-11
US8487074B2 (en) 2013-07-16
CA2650132C (en) 2017-10-24
WO2007126365A2 (en) 2007-11-08
PL2037950T3 (pl) 2014-09-30
JP6063401B2 (ja) 2017-01-18

Similar Documents

Publication Publication Date Title
SG171601A1 (en) Further medical uses of antisecretory protein
MX2008013777A (es) Usos medicos adicionales de la proteina antisecretora.
WO2010126626A3 (en) Dual mechanism inhibitors for the treatment of disease
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2011041462A3 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2008080082A3 (en) Methods for modulating set and uses thereof
WO2011041694A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2011017350A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2009108720A3 (en) Antagonists of prostaglandin d2 receptors
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2010141768A3 (en) Polycyclic antagonists of lysophosphatidic acid receptors
WO2010077882A3 (en) Antagonists of lysophosphatidic acid receptors
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2008076392A3 (en) Compounds useful as protein kinase inhibitors
WO2010003127A3 (en) Antagonists of prostaglandin d2 receptors
WO2012021629A3 (en) Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
WO2007106181A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2009050136A3 (en) Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome
WO2009145989A3 (en) Aminoalkylphenyl antagonists of prostaglandin d2 receptors
WO2010042652A3 (en) Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
IL194883A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol
WO2007120270A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2007120284A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2009038385A3 (en) Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
FG Grant or registration